Global Transconjunctival Sutureless Vitrectomy (TSV) Market Growth (Status and Outlook) 2026-2032

The global Transconjunctival Sutureless Vitrectomy (TSV) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Transconjunctival sutureless vitrectomy (TSV) is a surgical method that performs vitrectomy through a conjunctival incision and does not require sutures after surgery. It uses minimally invasive technology to precisely cut the vitreous while preserving the integrity of the eyeball, in order to achieve the purpose of treating diseases such as the vitreous, retina and macula. The surgery is performed through a conjunctival incision, avoiding the step of cutting the eyeball wall required in traditional surgery, thereby reducing surgical trauma and postoperative recovery time. High-precision surgical instruments and equipment are used to cut the cloudy vitreous, restore the transparent refractive medium, and promote retinal reattachment. The incision does not need to be sutured after surgery, and recovery relies on the natural healing ability of the conjunctiva, further reducing surgical risks and complications.

United States market for Transconjunctival Sutureless Vitrectomy (TSV) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Transconjunctival Sutureless Vitrectomy (TSV) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Transconjunctival Sutureless Vitrectomy (TSV) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Transconjunctival Sutureless Vitrectomy (TSV) players cover Bascom Palmer Eye Institute, Moorfields Eye Hospital, Massachusetts Eye and Ear Infirmary, Sichuan Provincial People's Hospital, Tongji Hospital Affiliated to Tongji University, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Transconjunctival Sutureless Vitrectomy (TSV) Industry Forecast” looks at past sales and reviews total world Transconjunctival Sutureless Vitrectomy (TSV) sales in 2025, providing a comprehensive analysis by region and market sector of projected Transconjunctival Sutureless Vitrectomy (TSV) sales for 2026 through 2032. With Transconjunctival Sutureless Vitrectomy (TSV) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transconjunctival Sutureless Vitrectomy (TSV) industry.

This Insight Report provides a comprehensive analysis of the global Transconjunctival Sutureless Vitrectomy (TSV) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transconjunctival Sutureless Vitrectomy (TSV) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transconjunctival Sutureless Vitrectomy (TSV) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transconjunctival Sutureless Vitrectomy (TSV) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transconjunctival Sutureless Vitrectomy (TSV).

This report presents a comprehensive overview, market shares, and growth opportunities of Transconjunctival Sutureless Vitrectomy (TSV) market by product type, application, key players and key regions and countries.

Segmentation by Type:
25G
23G

Segmentation by Application:
Ophthalmology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bascom Palmer Eye Institute
Moorfields Eye Hospital
Massachusetts Eye and Ear Infirmary
Sichuan Provincial People's Hospital
Tongji Hospital Affiliated to Tongji University
Tianjin Medical University Eye Hospital

Please note: The report will take approximately 2 business days to prepare and deliver. Show more